Five patents currently held, every record listed here
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Apr 2033. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Apr 2033
Next term end
5
Patent families
When these terms end
Each bar runs from grant to computed term end. 2017 to 2043.
US 12,758,679
Composition for Treating Wound Comprising Dermal Tissue-Derived Extracellular Matrix and Method for Preparing Same
Feb 6, 2042
US 12,741,051
Medical Composition Comprising Adipose Tissue-Derived Extracellular Matrix And Method For Preparing Same
Oct 22, 2042
US 12,611,485
Composite Demineralized Bone Matrix Composition Containing Bone Mineral Component and Method for Producing Same
Jan 20, 2043
202220272032203720422043
6 pending applications: term is not computable until grant.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.
Notable
Ends Apr 2033 · High confidence
Also notable
Ends Feb 2042 · High confidence
Acellular Dermal Graft
US 9,532,866
Granted 2017 and renewed at every maintenance window due so far. Protection runs to 2033.
Composition for Treating Wound Comprising Dermal Tissue-Derived Extracellular Matrix and Method for Preparing Same
US 12,758,679
Granted 2026. Too new for citation comparison; protection runs to 2042.
Formerly held, still cited
Notable
Ends Sep 2038 · High confidence
Granted 2022. Computed term ends 2038.
now held by L&C Futurelab Co., Ltd.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 10, 2027.
Recent changes
- 3 of the patents on this record were granted since Aug 17, 2026
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Decellularized Nerve Graft and Method of Manufacturing the Same | 1 in force | to May 2043 |
| Composite Demineralized Bone Matrix Composition Containing Bone Mineral Component and Method for Producing Same | 1 in force | to Jan 2043 |
| Medical Composition Comprising Adipose Tissue-Derived Extracellular Matrix And Method For Preparing Same | 1 in force | to Oct 2042 |
| Composition for Treating Wound Comprising Dermal Tissue-Derived Extracellular Matrix and Method for Preparing Same | 1 in force | to Feb 2042 |
| Acellular Dermal Graft | 1 in force | to Apr 2033 |
Patents held now
Soonest term end first.
Showing 1 to 5 of 5
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,532,866 | Acellular Dermal Graft In force · High confidence | In force | High confidence | |
| US 12,758,679 | Composition for Treating Wound Comprising Dermal Tissue-Derived Extracellular Matrix and Method for Preparing Same In force · High confidence | In force | High confidence | |
| US 12,741,051 | Medical Composition Comprising Adipose Tissue-Derived Extracellular Matrix And Method For Preparing Same In force · High confidence | In force | High confidence | |
| US 12,611,485 | Composite Demineralized Bone Matrix Composition Containing Bone Mineral Component and Method for Producing Same In force · High confidence | In force | High confidence | |
| US 12,721,930 | Decellularized Nerve Graft and Method of Manufacturing the Same In force · High confidence | In force | High confidence |
Also on record, not counted in the 5: 1 patent in force now held by others · 6 applications pending · 1 application abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.